NBIX vs WMK · P/E 45, rev $1.77B vs P/E 19, rev $2.53B
Neurocrine Biosciences Inc (NBIX) versus Weis Markets Inc (WMK) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Weis Markets Inc (WMK) is a grocery stores company listed on NYSE.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported WMK revenue for 2026-06-27 was $2.53B. Net income was $50.7M. WMK currently screens at market cap $1.89B and trailing P/E 18.9.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. WMK currently screens at market cap $1.89B and trailing P/E 18.9.
Not investment advice. Open the NBIX and WMK stock pages for the full models.
Not investment advice.